Methicillin-resistant Staphylococcus Aureus
Conditions
Keywords
methicillin-resistant Staphylococcus aureus, decolonization, random allocation, outpatient
Brief summary
The purpose of this study is to determine the effectiveness of topical and oral antibiotics in eliminating carriage of methicillin-resistant Staphylococcus aureus (MRSA) among those living in the community. We hypothesize that a greater proportion of those who receive intervention will eliminate MRSA carriage compared to those who do not receive any intervention.
Interventions
Chlorhexidine gluconate 4% body scrub and 2% shampoo daily PLUS mupirocin 2%, fusidic acid 2%, or chlorhexidine gluconate 0.2% intranasally bid PLUS trimethoprim-sulfamethoxazole 160/800mg po bid or doxycycline 100mg po bid all for 7 days
No pharmacological decolonization treatment but given education regarding personal hygiene and environmental cleaning
Sponsors
Study design
Eligibility
Inclusion criteria
* Prior MRSA infection (i.e index case) * Identified as being colonized with MRSA on initial screen
Exclusion criteria
* Are pregnant or breastfeeding. * Have indwelling catheters. * Received prior decolonization treatment within last 6 months of enrollment. * Have allergy to study medication. * Are colonized with MRSA strain resistant to study medication. * Have active infection requiring systemic antimicrobials. * Are household contacts to index case.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication of MRSA carriage | 90 days after randomization |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of MRSA infection | Within 6 months of randomization |
Countries
Canada